Guy Archibald Innes
CIK: 0001579377
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VOLITIONRX LTD
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Feb 26, 2026VNRX
VOLITIONRX LTD
Award(A)Direct178K shares- - Jan 22, 2026VNRX
VOLITIONRX LTD
Award(A)Direct12K shares- - Oct 14, 2025VNRX
VOLITIONRX LTD
Purchase(P)Direct96.2K shares at avg. $0.51$49K - Aug 5, 2025VNRX
VOLITIONRX LTD
Purchase(P)Direct78.1K shares at avg. $0.64$50K - Jun 3, 2025VNRX
VOLITIONRX LTD
Purchase(P)Direct20K shares at avg. $0.54$11K - Mar 26, 2025VNRX
VOLITIONRX LTD
Purchase(P)Direct181.8K shares at avg. $0.55$100K - Mar 1, 2025VNRX
VOLITIONRX LTD
Award(A)Direct19.8K shares- - Jan 29, 2025VNRX
VOLITIONRX LTD
Award(A)DirectStock Option (Right to Buy)
25K shares- - Jan 29, 2025VNRX
VOLITIONRX LTD
Disposition(D)DirectStock Option (Right to Buy)
25K shares- - Jan 15, 2025VNRX
VOLITIONRX LTD
Award(A)Direct50K shares- - Dec 9, 2024VNRX
VOLITIONRX LTD
Purchase(P)Direct174.8K shares at avg. $0.57$100K - Dec 1, 2024VNRX
VOLITIONRX LTD
Award(A)Direct17.3K shares- - Sep 1, 2024VNRX
VOLITIONRX LTD
Award(A)Direct18.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | VNRX VOLITIONRX LTD | Award(A) | 178,000 | - | $0 | Direct |
| Jan 22, 2026 | VNRX VOLITIONRX LTD | Award(A) | 12,000 | - | $0 | Direct |
| Oct 14, 2025 | VNRX VOLITIONRX LTD | Purchase(P) | 96,153 | $0.51 | $49,038 | Direct |
| Aug 5, 2025 | VNRX VOLITIONRX LTD | Purchase(P) | 78,125 | $0.64 | $50,000 | Direct |
| Jun 3, 2025 | VNRX VOLITIONRX LTD | Purchase(P) | 20,000 | $0.54 | $10,772 | Direct |
| Mar 26, 2025 | VNRX VOLITIONRX LTD | Purchase(P) | 181,818 | $0.55 | $100,000 | Direct |
| Mar 1, 2025 | VNRX VOLITIONRX LTD | Award(A) | 19,786 | - | - | Direct |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | Award(A) Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 29, 2025 | VNRX VOLITIONRX LTD | Disposition(D) Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Jan 15, 2025 | VNRX VOLITIONRX LTD | Award(A) | 50,000 | - | $0 | Direct |
| Dec 9, 2024 | VNRX VOLITIONRX LTD | Purchase(P) | 174,764 | $0.57 | $100,000 | Direct |
| Dec 1, 2024 | VNRX VOLITIONRX LTD | Award(A) | 17,296 | - | $0 | Direct |
| Sep 1, 2024 | VNRX VOLITIONRX LTD | Award(A) | 18,342 | - | $0 | Direct |
1-13 of 13 transactions
About Innes Guy Archibald
Innes Guy Archibald (SEC CIK 0001579377) files insider reports with the SEC as Director of VOLITIONRX LTD (VNRX).
Signal8 holds 12 ownership filings by Innes Guy Archibald, all Form 4s, filed between Sep 4, 2024 and Feb 27, 2026. Those filings report 13 transactions, from Sep 1, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Innes Guy Archibald's filings is in HENDERSON, NV.
Recent filings by Innes Guy Archibald
- Feb 26, 2026: Grant or award of VNRX shares (Form 4, code A).
- Jan 22, 2026: Grant or award of VNRX shares (Form 4, code A).
- Oct 14, 2025: Open-market purchase of VNRX shares (Form 4, code P).
- Aug 5, 2025: Open-market purchase of VNRX shares (Form 4, code P).
- Jun 3, 2025: Open-market purchase of VNRX shares (Form 4, code P).
Other insiders filing for VOLITIONRX LTD (VNRX)
- Batchelor Ann-Louise, Group Chief Marketing Officer
- Forterre Gael, Chief Commercial Officer
- Rootsaert Rodney Gerard, Secretary
- Micallef Jacob Vincent, Chief Scientific Officer
- Plummer Nicholas, GC - Volition Diagnostics
- Rubin Ethel, Director